Nancy Miller-Rich
CIK 1735084 · last filed 2026-06-11
Nancy Miller-Rich is a corporate insider who has filed 24 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for ALDX, was dated Jun 11, 2026. Across all open-market trades the lifetime net is +$10.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $727 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$727
4
24
$10.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALDX | Director | 413 | $1.76 | $727 | $10.4K | 9 | 2026-06-11 |
| FDMT | Director | — | $8.83 | — | $0 | 5 | 2025-06-20 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 30,415 | $19.00 | $577.9K | $0 | 6 | 2023-05-25 |
| Kadmon Holdings, Inc. (KDMN) Delisted | Director | — | $9.50 | — | $0 | 3 | 2021-11-09 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2024-10-21 | ALDX | Buy (P) | +922 | $10.4K | EDGAR |
| 2024-06-06 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −30,415 | -$577.9K | |
| 2023-07-05 | ALDX | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | FDMT | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +8,111 | $0 | EDGAR |